Published in J Exp Med on May 01, 1992
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun (1999) 3.15
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun (1998) 2.44
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun (1994) 1.92
Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci U S A (1994) 1.85
Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun (2002) 1.78
Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun (1997) 1.68
Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis. J Exp Med (1998) 1.35
Two capsular polysaccharides enable Bacillus cereus G9241 to cause anthrax-like disease. Mol Microbiol (2011) 1.11
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
Culture Conditions Affect the Molecular Weight Properties of Hyaluronic Acid Produced by Streptococcus zooepidemicus. Appl Environ Microbiol (1997) 1.04
Complete genome sequence and immunoproteomic analyses of the bacterial fish pathogen Streptococcus parauberis. J Bacteriol (2011) 0.90
Thermoregulation of capsule production by Streptococcus pyogenes. PLoS One (2012) 0.85
A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. J Bacteriol (2012) 0.82
Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus. J Biol Chem (2014) 0.80
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38
TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med (1943) 17.30
Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro. J Exp Med (1960) 12.03
Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of "conjugal" transfer in the absence of a conjugative plasmid. J Bacteriol (1981) 11.15
Regeneration of insertionally inactivated streptococcal DNA fragments after excision of transposon Tn916 in Escherichia coli: strategy for targeting and cloning of genes from gram-positive bacteria. J Bacteriol (1984) 6.82
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med (1987) 5.58
Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol (1986) 5.08
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci. J Exp Med (1959) 3.41
THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med (1944) 3.39
Genetic manipulation of pathogenic streptococci. Methods Enzymol (1991) 3.34
Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice. J Exp Med (1948) 3.31
Sequence analysis of termini of conjugative transposon Tn916. J Bacteriol (1988) 3.22
Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med (1958) 3.16
Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr Top Microbiol Immunol (1990) 2.64
Genome walking by single-specific-primer polymerase chain reaction: SSP-PCR. Gene (1989) 2.20
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Insertional inactivation of streptolysin S expression in Streptococcus pyogenes. J Bacteriol (1983) 2.13
The biosynthesis of hyaluronic acid by group A Streptococcus. VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem (1959) 2.04
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
THE ENZYMATIC SYNTHESIS IN VITRO OF HYALURONIC ACID CHAINS. Proc Natl Acad Sci U S A (1955) 1.54
Streptococcal hyaluronic acid: proposed mechanisms of degradation and loss of synthesis during stationary phase. J Bacteriol (1983) 1.26
Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med (1985) 1.09
Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies. J Exp Med (1988) 0.93
Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. J Exp Med (1986) 0.91
Isolation of streptococcal hyaluronate synthase. Biochem J (1986) 0.91
Naturally-occurring antibodies which bind hyaluronate. Biochem Biophys Res Commun (1982) 0.88
Solubilization of hyaluronic acid synthetic activity from streptococci and its activation with phospholipids. J Biol Chem (1986) 0.85
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80
Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98
Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore. J Bacteriol (1981) 2.17
Lysis of grouped and ungrouped streptococci by lysozyme. Infect Immun (1970) 2.09
Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem (1999) 1.90
Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem (1995) 1.81
Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose dehydrogenase activity. J Biol Chem (1993) 1.78
Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62
Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. J Biol Chem (1994) 1.54
The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med (1979) 1.31
Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci. J Exp Med (1979) 1.29
Immunochemical study of nutritionally variant streptococci. J Immunol (1984) 1.28
Characterization of a pH-dependent chromophore from nutritionally variant streptococci. Infect Immun (1984) 1.27
Synthesis of 5-azido-UDP-N-acetylhexosamine photoaffinity analogs and radiolabeled UDP-N-acetylhexosamines. Anal Biochem (1998) 1.26
Streptococcal hyaluronic acid: proposed mechanisms of degradation and loss of synthesis during stationary phase. J Bacteriol (1983) 1.26
Chemical analysis of changes in membrane composition during growth of Streptococcus pyogenes. Infect Immun (1979) 1.24
Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology (1991) 1.23
Enzyme-linked immunosorbent assay for the detection of antibodies to nutritionally variant streptococci in patients with endocarditis. J Infect Dis (1986) 1.20
Properties and kinetic analysis of UDP-glucose dehydrogenase from group A streptococci. Irreversible inhibition by UDP-chloroacetol. J Biol Chem (1997) 1.17
Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose pyrophosphorylase activity. J Biol Chem (1995) 1.16
Quantitative immunoelectrophoretic analysis of Streptococcus pyogenes membrane. Infect Immun (1979) 1.13
Nutritionally variant streptococcal serotype I antigen. Characterization as a lipid-substituted poly(ribitol phosphate). J Immunol (1988) 1.02
Role of culture conditions and immunization in experimental nutritionally variant streptococcal endocarditis. Infect Immun (1985) 0.96
Analysis of adherence of Streptococcus defectivus and endocarditis-associated streptococci to extracellular matrix. Infect Immun (1991) 0.96
Quantitative analysis of cell walls of nutritionally variant streptococci grown under various growth conditions. Infect Immun (1985) 0.95
Identification of bacterial antigens in circulating immune complexes of infective endocarditis. J Clin Invest (1982) 0.94
Serial studies on circulating immune complexes in post-streptococcal sequelae. Clin Exp Immunol (1978) 0.93
Immunological studies of post-streptococcal sequelae: serological studies with an extracellular protein associated with nephritogenic streptococci. Clin Exp Immunol (1983) 0.88
Purification of serotype I antigen from nutritionally variant streptococci. Infect Immun (1988) 0.88
Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. J Clin Invest (1984) 0.87
Solubilization of hyaluronic acid synthetic activity from streptococci and its activation with phospholipids. J Biol Chem (1986) 0.85
Effects of penicillin on group A streptococci: loss of viability appears to precede stimulation of release of lipoteichoic acid. Antimicrob Agents Chemother (1981) 0.84
Identification of the surface component of Streptococcus defectivus that mediates extracellular matrix adherence. Infect Immun (1993) 0.83
Characterization of emb, a gene encoding the major adhesin of Streptococcus defectivus. Infect Immun (1999) 0.83
Lymphocytes binding C-reactive protein and streptococcal membranes in acute rheumatic fever. J Lab Clin Med (1980) 0.78
Purification and characterization of Streptococcus adjacens (nutritionally variant Streptococcus serotype II) group antigen. Infect Immun (1991) 0.77
Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance. J Clin Microbiol (1991) 0.75
Characterization of the Streptococcus adjacens group antigen structure. J Bacteriol (1992) 0.75
Changes in T-lymphocyte subsets during acute rheumatic fever. J Clin Immunol (1982) 0.75
Evaluation of the immune response in protection against experimental Streptococcus defectivus endocarditis. J Lab Clin Med (1991) 0.75